focus trial semaglutide Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised SELECT Trial

Take 80-125mg after meals or when burping becomes bothersome

Methods Data sources The study was conducted using the Truveta electronic health record (EHR) database, which aggregates de-identified patient data from 30 health systems across all 50 US states

Endocrine (2020) 68:51825

Open Diabetes Res Care 2021;9(1):e002127

Ozempic is safe and effective when used as indicated for the treatment of adults with type 2 diabetes to lower blood sugar, along with diet and exercise, reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who also have heart disease, and lower the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes who also have chronic kidney disease